Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 TREATMENT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 EPIDEMIOLOGY: MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET
4.4 DRUG TREATMENT RATE BY MATURED MARKETS: MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET
4.5 DRUG
4.6 WORD PIPELINE
5 REGULATORY FRAMEWORK FOR THE MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET
5.1 REGULATORY APPROVAL PATHWAYS
5.2 LICENSING AND REGISTRATION
5.3 REGULATORY APPROVAL PATHWAYS
5.4 LICENSING AND REGISTRATION
5.5 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF OBESITY
6.1.2 INNOVATIONS IN ANTI-OBESITY MEDICATIONS
6.1.3 GROWTH IN BARIATRIC AND METABOLIC SURGERIES.
6.1.4 INTEGRATION OF DIGITAL HEALTH SOLUTIONS IN OBESITY TREATMENT
6.2 RESTRAINTS
6.2.1 ANTI-OBESITY DRUGS AND SURGICAL INTERVENTIONS CARRY RISKS
6.2.2 HIGH RELAPSE RATES POST-TREATMENT OF OBESITY
6.3 OPPORTUNITIES
6.3.1 INCREASING PREVALENCE OF LIFESTYLE RELATED DISEASES
6.3.2 RISING DISPOSABLE INCOME ENHANCING THE PURCHASING POWER FOR OBESITY TREATMENT RELATED PRODUCTS
6.3.3 RISE IN STRATEGIC INITIATIVES AND LAUNCHES BY MARKET PLAYERS
6.4 CHALLENGES
6.4.1 LONG-TERM FOLLOW-UPS ASSOCIATED WITH OBESITY TREATMENT
6.4.2 ADDRESSAL OF THE LIFESTYLE AND BEHAVIORAL CHANGES
7 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY TREATMENT TYPE
7.1 OVERVIEW
7.2 PHARMACOLOGICAL TREATMENTS (ANTI-OBESITY DRUGS)
7.2.1 GLP-1 RECEPTOR AGONISTS
7.2.2 DUAL GIP/ GLP-1 RECEPTOR AGONISTS
7.2.2.1 Phentermine
7.2.2.2 Phentermine-Topiramate
7.2.2.3 Naltrexone-Bupropion
7.2.3 LIPASE INHIBITORS
7.2.4 DEOXYCHOLIC ACID
7.2.5 OTHERS
7.3 BARIATRIC SURGERY
7.3.1 RESTRICTIVE SURGERIES
7.3.1.1 Sleeve gastrectomy
7.3.1.2 Adjustable gastric banding
7.3.2 COMBINATION SURGERIES
7.3.2.1 Roux-en-Y gastric bypass (RYGB)
7.3.2.2 Mini-gastric bypass (MGB)
7.3.3 MALABSORPTIVE SURGERIES
7.3.3.1 Laparoscopic Surgery
7.3.3.2 Robotic-Assisted Surgery
7.3.3.3 Open Surgery
7.4 BEHAVIORAL & LIFESTYLE THERAPY
7.4.1 DIETARY INTERVENTIONS
7.4.2 BEHAVIORAL MODIFICATION THERAPY
7.4.3 PHYSICAL ACTIVITY PROGRAMS
7.4.4 PSYCHOLOGICAL COUNSELING
7.5 NON-INVASIVE/ ENDOSCOPIC PROCEDURES
7.5.1 ENDOSCOPIC SLEEVE GASTROPLASTY (ESG)
7.5.2 INTRAGASTRIC BALLOON (IGB)
7.5.2.1 Orbera intragastric balloon
7.5.2.2 Spatz adjustable balloon system
7.5.3 ASPIRATION THERAPY (ASPIREASSIST)
7.5.4 TRANSORAL GASTROPLASTY (TOGA)
7.6 MEDICAL DEVICES & TECHNOLOGIES
7.6.1 ARTIFICIAL INTELLIGENCE & DIGITAL WEIGHT MANAGEMENT PLATFORMS
7.6.2 GASTRIC ELECTRICAL STIMULATION DEVICES (MAESTRO SYSTEM)
8 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 ADULT OBESITY TREATMENT
8.3 GERIATRIC OBESITY TREATMENT
8.4 PEDIATRIC OBESITY TREATMENT
9 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 ONLINE PHARMACIES
9.3 RETAIL PHARMACIES
9.4 WEIGHT MANAGEMENT CLINICS
9.5 HOSPITAL PHARMACIES
9.6 WELLNESS & FITNESS CENTERS
10 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 CLASS III
10.3 CLASS II
10.4 CLASS I
11 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY REGION
11.1 MIDDLE EAST AND AFRICA
11.1.1 SAUDI ARABIA
11.1.2 EGYPT
11.1.3 KUWAIT
11.1.4 SOUTH AFRICA
11.1.5 UNITED ARAB EMIRATES
11.1.6 ISRAEL
11.1.7 REST OF MIDDLE EAST AND AFRICA
12 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 NOVO NORDISK A/S
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 ELI LILLY AND COMPANY
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT/NEWS
14.3 MEDTRONIC
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.4 BOSTON SCIENTIFIC CORPORATION
14.4.1 COMPANY SNAPSHOTS
14.4.2 REVENUE ANALYSIS AND SEGMENTED ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 JOHNSON & JOHNSON SERVICES, INC.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT/NEWS
14.6 ALTIMMUNE
14.6.1 COMPANY SNAPSHOT
14.6.2 PIPELINE PORTFOLIO
14.6.3 RECENT UPDATES
14.7 ASTRAZENECA
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT/NEWS
14.8 ALLURION
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
1.1.5 RECENT DEVELOPMENT/NEWS 206
14.9 AMGEN
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
1.1.13 RECENT DEVELOPMENT/NEWS 211
14.1 ARENA PHARMACEUTICALS LTD
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 CURRAX PHARMACEUTICALS LLC
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 COUSIN SURGERY
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 F. HOFFMANN-LA ROCHE LTD
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT/NEWS
14.14 FITTERFLY HEALTHTECH PVT. LTD.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 MORPHIC MEDICAL, INC
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 NOOM, INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 OMADA HEALTH INC
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 RESHAPE LIFESCIENCES
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
1.1.7 RECENT DEVELOPMENT/NEWS 230
14.19 RAZIEL
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 SPATZ FGIA INC.
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 SANOFI
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENT
14.22 SANIONA
14.22.1 COMPANY SNAPSHOT
14.22.2 REVENUE ANALYSIS
14.22.3 PRODUCT PORTFOLIO
14.22.4 RECENT DEVELOPMENT
14.23 USGI MEDICAL
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.24 VIVUS LLC.
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT/NEWS
14.25 VIKING THERAPEUTICS
14.25.1 COMPANY SNAPSHOTS
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 ZEALAND PHARMA
14.26.1 COMPANY SNAPSHOT
14.26.2 REVENUE ANALYSIS
14.26.3 PRODUCT PORTFOLIO
14.26.4 RECENT DEVELOPMENT/NEWS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 OBESITY PREVALENCE BY REGION (ADULTS)
TABLE 2 OBESITY PREVALENCE BY GENDER (ADULTS)
TABLE 3 OBESITY PREVALENCE BY AGE (ADULTS)
TABLE 4 MIDDLE EAST AND AFRICA CLINICAL TRIAL MARKET FOR OBESITY TREATMENT
TABLE 5 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET
TABLE 6 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET
TABLE 7 MIDDLE EAST AND AFRICA OBESITY STATISTICS (2022)
TABLE 8 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 MIDDLE EAST AND AFRICA PHARMACOLOGICAL TREATMENTS (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 MIDDLE EAST AND AFRICA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 MIDDLE EAST AND AFRICA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 24 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA ADULT OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 MIDDLE EAST AND AFRICA GERIATRIC OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 27 MIDDLE EAST AND AFRICA PEDIATRIC OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 28 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 29 MIDDLE EAST AND AFRICA ONLINE PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 30 MIDDLE EAST AND AFRICA RETAIL PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 31 MIDDLE EAST AND AFRICA WEIGHT MANAGEMENT CLINICS IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 32 MIDDLE EAST AND AFRICA HOSPITAL PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 33 MIDDLE EAST AND AFRICA WELLNESS & FITNESS CENTERS IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 34 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 MIDDLE EAST AND AFRICA CLASS III IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 36 MIDDLE EAST AND AFRICA CLASS II IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 37 MIDDLE EAST AND AFRICA CLASS I IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 39 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 MIDDLE EAST AND AFRICA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 MIDDLE EAST AND AFRICA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 MIDDLE EAST AND AFRICA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 MIDDLE EAST AND AFRICA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 53 SAUDI ARABIA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 54 SAUDI ARABIA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 SAUDI ARABIA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 56 SAUDI ARABIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 SAUDI ARABIA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 58 SAUDI ARABIA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 59 SAUDI ARABIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 60 SAUDI ARABIA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 SAUDI ARABIA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 SAUDI ARABIA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 SAUDI ARABIA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 SAUDI ARABIA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 65 SAUDI ARABIA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 66 SAUDI ARABIA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 EGYPT OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 68 EGYPT PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 69 EGYPT CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 EGYPT BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 71 EGYPT RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 EGYPT COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 73 EGYPT BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 74 EGYPT BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 EGYPT NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 EGYPT INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 77 EGYPT MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 EGYPT OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 79 EGYPT OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 80 EGYPT OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 KUWAIT OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 KUWAIT PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 KUWAIT CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 84 KUWAIT BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 KUWAIT RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 KUWAIT COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 87 KUWAIT BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 88 KUWAIT BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 KUWAIT NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 KUWAIT INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 91 KUWAIT MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 KUWAIT OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 93 KUWAIT OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 94 KUWAIT OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 SOUTH AFRICA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 SOUTH AFRICA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 SOUTH AFRICA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 SOUTH AFRICA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 SOUTH AFRICA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 SOUTH AFRICA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 101 SOUTH AFRICA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 102 SOUTH AFRICA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 SOUTH AFRICA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 SOUTH AFRICA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 SOUTH AFRICA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 SOUTH AFRICA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 107 SOUTH AFRICA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 108 SOUTH AFRICA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 UNITED ARAB EMIRATES OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 110 UNITED ARAB EMIRATES PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 UNITED ARAB EMIRATES CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 UNITED ARAB EMIRATES BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 UNITED ARAB EMIRATES RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 114 UNITED ARAB EMIRATES COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 115 UNITED ARAB EMIRATES BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 116 UNITED ARAB EMIRATES BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 UNITED ARAB EMIRATES NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 UNITED ARAB EMIRATES INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 119 UNITED ARAB EMIRATES MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 UNITED ARAB EMIRATES OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 121 UNITED ARAB EMIRATES OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 122 UNITED ARAB EMIRATES OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 123 ISRAEL OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 ISRAEL PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 ISRAEL CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 126 ISRAEL BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 127 ISRAEL RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 ISRAEL COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 129 ISRAEL BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)
TABLE 130 ISRAEL BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 ISRAEL NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 ISRAEL INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 ISRAEL MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 ISRAEL OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 135 ISRAEL OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 136 ISRAEL OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 REST OF MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)
List of Figure
FIGURE 1 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: LIFELINE CURVE
FIGURE 7 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: SEGMENTATION
FIGURE 12 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 FIVE SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET , BY TREATMENT TYPE
FIGURE 15 RISING PREVALENCE OF OBESITY IS EXPECTED TO DRIVE THE GROWTH OF MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET FROM 2025 TO 2032
FIGURE 16 THE PHARMACOLOGICAL TREATMENTS (ANTI-OBESITY DRUGS) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET IN 2025 - 2032
FIGURE 17 MARKET OVERVIEW
FIGURE 18 PREVALENCE OF OBESITY IN ADULTS AGE 20 AND OLDER, BY SEX AND AGE: UNITED STATES, AUGUST 2021–AUGUST 2023 SOURCE: CENTERS FOR DISEASE CONTROL AND PREVENTION.
FIGURE 19 SHARE OF PRE-OBESE AND OBESE PERSONS AGED 16 YEARS OR OVER, BY SEX, 2022 (%)
FIGURE 20 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY TREATMENT TYPE, 2024
FIGURE 21 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY TREATMENT TYPE, 2025-2032 (USD THOUSAND)
FIGURE 22 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2025-2032)
FIGURE 23 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY AGE GROUP, 2024
FIGURE 25 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY AGE GROUP, 2025-2032 (USD THOUSAND)
FIGURE 26 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY AGE GROUP, CAGR (2025-2032)
FIGURE 27 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 29 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD THOUSAND)
FIGURE 30 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 31 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY PATIENT TYPE, 2024
FIGURE 33 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY PATIENT TYPE, 2025-2032 (USD THOUSAND)
FIGURE 34 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY PATIENT TYPE, CAGR (2025-2032)
FIGURE 35 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: SNAPSHOT (2024)
FIGURE 37 MIDDLE EAST AND AFRICA OBESITY TREATMENT MARKET: COMPANY SHARE 2024 (%)
